FDA Determines Regulatory Review Period for Progel Pleural Air Leak Sealant Patent Extension

Summary

The FDA has published a notice determining the regulatory review period for Progel Pleural Air Leak Sealant, a medical device, in response to a patent extension application submitted to the Director of Patents and Trademarks at the US Department of Commerce.